Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors

Published:2011-12 Issue:23 Volume:19 Page:7120-7128
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Mathew Bini,Srivastava Shefali,Ross Larry J.,Suling William J.,White E. Lucile,Woolhiser Lisa K.,Lenaerts Anne J.,Reynolds Robert C.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference21 articles.

1. Discovery and validation of new antitubercular compounds as potential drug leads and probes

2. The challenge of new drug discovery for tuberculosis

3. FtsZ, a prokaryotic homolog of tubulin?

4. Discovery of a Small Molecule That Inhibits Cell Division by Blocking FtsZ, a Novel Therapeutic Target of Antibiotics

5. Targeting cell division: Small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ligand-based pharmacophore modelling, virtual screening and docking studies to identify potential compounds against FtsZ of Mycobacterium tuberculosis;Indian Journal of Tuberculosis;2023-10

2. Anti-Tubercular Activity of Pyrazinamide Conjugates: Synthesis and Structure-Activity Relationship Studies;Mini-Reviews in Medicinal Chemistry;2023-04

3. Multicomponent synthesis of pyrido[2,3-b]pyrazine derivatives: electrochemical DNA sensing, nonlinear optical properties and biological activity;RSC Advances;2023

4. Filamentous temperature sensitive mutant Z: a putative target to combat antibacterial resistance;RSC Advances;2023

5. An open label phase II study of safety and clinical activity of naltrexone for treatment of hormone refractory metastatic breast cancer;Investigational New Drugs;2022-11-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3